The role of chromosomal aberrations in premalignant and malignant lesions in head and neck squamous cell carcinoma.
The objectives of this study are to uncover the molecular mechanisms involved in head and neck squamous cell carcinoma (HNSCC) pathogenesis by studying the chromosomal aberrations in both premalignant and malignant patients and to highlight the genotype of HNSCC in Upper Egypt. From March 2001 to December 2003, prospective study was conducted in 41 patients with precancerous, 79 patients with cancerous laryngeal, oesophageal, nasopharyngeal, nasal, and oral lesions and 50 controls in ENT department, Sohag Faculty of Medicine, Sohag, Egypt. Samples taken by punch biopsy were frozen and stored at -80 degrees C and were subjected to histopathological examination. Metaphase cells were digitally imaged and karyotyped. Karyotypes have been analysed via anatomical image capture and compared with standard human chromosome ideograms. In precancerous lesions, there were 41% 3p loss, 51% 3q gain, 29% 8q gain, and 22% 11q13 gain. In malignant lesions, there were 63% 3p13-p24 loss, 59.5% 5q12-23 loss, 49.5% 8p22-p23 loss, 45.5% 9p21-p24 loss, 40.5% 18q22-q23 loss, 66% 3q gain, 39% 8q gain, and 16% 11q13 gain. In conclusion, early diagnosis of HNSCC can be achieved by DNA extraction from suspicious lesions in high-risk groups (smokers and alcoholics) and examination of chromosomal aberrations of 3p, 3q, 8q, and 11q13. If there are high percent of chromosomal aberrations in these chromosomes, active intervention should be done (chemoprevention and regular follow-up of head and neck examination for very early detection and management).
Abou-Elhamd
Kamal-Eldin Ahmed
KE
Sohag Faculty of Medicine, Sohag University, Sohag, Egypt. kamal375@yahoo.com
Habib
Tito Naeem
TN
D002294:Carcinoma, Squamous Cell / Q000235:genetics*; D002869:Chromosome Aberrations; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D020440:Gene Duplication; D005838:Genotype; D006801:Humans; D007621:Karyotyping; D007822:Laryngeal Neoplasms / Q000235:genetics*; D011230:Precancerous Conditions / Q000235:genetics*
Head Neck. 1998 Mar;20(2):145-51
9484946
Cancer Res. 1995 Jul 15;55(14):3055-9
7606727
Int J Cancer. 1988 Feb 15;41(2):184-97
3338870
Int J Cancer. 1991 Jun 19;48(4):511-5
2045198
Clin Otolaryngol Allied Sci. 1995 Jun;20(3):266-71
7554343
Can J Genet Cytol. 1986 Apr;28(2):317-22
3719454
Cancer Metastasis Rev. 1996 Mar;15(1):3-10
8842476
Otolaryngol Head Neck Surg. 1998 Mar;118(3 Pt 1):363-70
9527118
J Korean Med Sci. 2004 Jun;19(3):345-51
15201498
Cancer Res. 1994 Mar 1;54(5):1156-8
8118798
Proc Natl Acad Sci U S A. 1982 Dec;79(24):7842-6
6961456
Nat Med. 1996 Jun;2(6):682-5
8640560
Anticancer Res. 1985 Mar-Apr;5(2):221-4
2581495
Oncogene. 1999 Apr 22;18(16):2651-5
10353609
J Med Assoc Thai. 1997 Apr;80(4):207-18
9175390
Exp Cell Res. 1972 Nov;75(1):304-6
4117921
Cancer. 1993 Aug 1;72(3):881-6
8101470
Cancer Res. 1989 Sep 15;49(18):5167-75
2766286
Aust N Z J Surg. 1997 Jul;67(7):410-6
9236604
Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9
11489748
Laryngoscope. 2002 Jun;112(6):1094-9
12160280
J Pathol. 2001 Jun;194(2):177-82
11400146
Clin Cancer Res. 2000 Feb;6(2):357-62
10690511